兰索拉唑联合莫沙必利片治疗反流性食管炎的临床观察  

Lansoprazole Combine Mosapride Tablets in the Treatment of Reflux Esophagitis Observation

作　　者：司君圣 胡延丽[1] 

机构地区：[1]烟台经济技术开发区医院消化科,山东烟台264006

出　　处：《中国医药指南》2013年第23期11-12,共2页Guide of China Medicine

摘　　要：目的探讨兰索拉唑联合莫沙必利治疗反流性食管炎的临床疗效。方法选择我院2010年至2013年80例反流性食管炎患者的资料,根据其治疗方式分为观察组及对照组,各40例,对照组采用兰索拉唑治疗,观察组患者应用兰索拉唑联合莫沙必利片治疗,随访8周,对两组患者的治疗效果进行评价。结果观察组患者症状及镜下改善均优于对照组,比较差异有统计学意义(P<0.05)。结论兰索拉唑联合莫沙必利治疗反流性食管炎,可有效缓解患者症状,值得在临床推广。Objective To investigate the lansoprazole mosapride clinical efficacy for the treatment of reflux esophagitis. Method In our hospital from 2010 to 2013, 80 patients with reflux esophagitis patients, divided into two groups according to their treatment and control group, 40 patients in the control group, lansoprazole treatment, the observation group patients lansoprazole joint mosapride the Lee tablets in the treatment, followed up for 8 weeks to evaluate the therapeutic effect of the two groups of patients. Results The patients symptoms and endoscopic improvement than the control group, the difference was statistically significant （P〈0.05）. Conclusion Lansoprazole mosapride treatment of reflux esophagitis, which can effectively alleviate the symptoms, worthy of promotion.

关 键 词：兰索拉唑 莫沙必利片 反流性食管炎 临床疗效 

分 类 号：R571[医药卫生—消化系统]